Ohr Pharmaceutical, Inc. (OHRP)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
2.82+0.01 (+0.19%)
As of 10:21 AM EDT. Market open.
People also watch:
MEIPPBMDCNATAQXPONTX
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open2.82
Prev Close2.81
Bid2.78 x 200
Ask2.84 x 100
Day's Range2.79 - 2.82
52wk Range2.44 - 6.56
1y Target EstN/A
Market Cap90.38M
P/E Ratio (ttm)-3.78
Beta1.61
Volume5,025
Avg Vol (3m)78,210
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • GlobeNewswire6 days ago

    TiGenix Appoints Dr. June Almenoff to its Board of Directors

    PRESS RELEASE TiGenix Appoints Dr. June Almenoff to its Board of Directors Leuven (BELGIUM) - September 22, 2016, 07:00h CET - TiGenix NV (Euronext Brussels: TIG), an advanced biopharmaceutical company ...

  • Ohr Pharmaceutical, Inc. :OHRP-US: Earnings Analysis: Q3, 2016 By the Numbers : September 20, 2016
    Capital Cube8 days ago

    Ohr Pharmaceutical, Inc. :OHRP-US: Earnings Analysis: Q3, 2016 By the Numbers : September 20, 2016

    Categories: Yahoo Finance Get free summary analysis Ohr Pharmaceutical, Inc. reports financial results for the quarter ended June 30, 2016. Analysis Summary numbers: Revenues of USD 0 million, Net Earnings of USD -7.70 million. The company did not record any revenues for the last twelve months making the comparison of net margin versus asset turnover meaningless. OHRP-US‘s earnings ... Read more (Read more...)

  • Associated Press2 months ago

    OHR reports 3Q loss

    On a per-share basis, the New York-based company said it had a loss of 24 cents. In the final minutes of trading on Tuesday, the company's shares hit $2.72. A year ago, they were trading at $2.32. _____ ...